ISR Activation & Apoptosis via HRI Kinase by PG3 and Other p53 Cancer Therapies
September 18, 2024
Our results provide unique insights into the mechanism of action of PG3 as a novel cancer therapeutic targeting p53 pathway-like tumor suppression.”BUFFALO, NY- September 18, 2024 – A new research... read more